Granulocyte-colony stimulating factor (G-CSF) is a cornerstone of supportive care in oncology, widely used to prevent chemotherapy-induced neutropenia and maintain dose intensity and treatment schedule. The gene discussed is CSF3; the disease is Decreased total neutrophil count.